EQUITY (Tables)

3 Months Ended

Mar. 31, 2025

SCHEDULE OF FAIR VALUE OF OPTION USING VALUATION ASSUMPTIONS

The Company utilized the Black-Scholes option-pricing model to estimate fair value, utilizing the following assumptions for the options issued during the three months ended March 31, 2024 (all in weighted averages):

Risk-free interest rate		3.5	%
Expected term of options, in years		4.00
Expected annual volatility		191.1	%
Expected dividend yield		0	%
Determined weighted average grant date fair value per option	$	0.19

SCHEDULE OF STOCK OPTION ACTIVITIES

A summary of the Company’s option plans for the three months ended March 31, 2025, is presented below (unaudited):

SCHEDULE OF STOCK OPTION ACTIVITIES

	Number		Weighted
	of		Average
	Options		Exercise
	(in shares)		Price
Outstanding, December 31, 2024		6,360,000	$	0.13
Granted		-		-
Outstanding, March 31, 2025		6,360,000	$	0.13
Exercisable, March 31, 2025		6,360,000	$	0.13

SUMMARY OF WARRANTS ACTIVITY

The Company has issued warrants at exercise prices equal to or greater than the market value of the Company’s common stock at the date of issuance. A summary of warrant activity follows (unaudited):

SUMMARY OF WARRANTS ACTIVITY

	Number of		Weighted
	shares		Average
	underlying		Exercise
	warrants		Price
Outstanding, December 31, 2024		3,000,000	$	0.12
Granted		-		-
Exercised		-		-
Forfeited or expired		-		-
Outstanding, March 31, 2025		3,000,000	$	0.12

NovelStem International Corp. 10-Q